'One injection protects up to six months': what is new HIV drug lenacapavir?

New long-acting antiretroviral treatment lenacapavir requires just two injections a year, reducing the need for daily pills. But questions remain over access, cost and whether enough doses will be available to meet demand in the country with the world's largest HIV-positive population.